As of midnight last night, Pfizer completed the acquisition of Medivation and therefore enzalutamide (Xtandi) is now being sold in the USA by Pfizer and Astellas and by Astellas in the rest of the world. For the details, see here.
Filed under: Uncategorized | Tagged: enzalutamide, Medivation, Pfizer, Xtandi | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 